Prostate Cancer News and Research

Latest Prostate Cancer News and Research

GTx reports net loss of $2.6 million for first quarter 2011

GTx reports net loss of $2.6 million for first quarter 2011

9 May 2011
Enzon first quarter adjusted loss from continuing operations decreases to $4.2 million

Enzon first quarter adjusted loss from continuing operations decreases to $4.2 million

7 May 2011
Surgery reduces mortality risk of prostate cancer

Surgery reduces mortality risk of prostate cancer

6 May 2011
CanTeen launches groundbreaking cancer support system

CanTeen launches groundbreaking cancer support system

5 May 2011
CytRx reports $6.3 million net loss for first quarter 2011

CytRx reports $6.3 million net loss for first quarter 2011

5 May 2011
Theragenics reports consolidated revenue of $20.3 million for first quarter 2011

Theragenics reports consolidated revenue of $20.3 million for first quarter 2011

5 May 2011
Four medical centers enroll additional patients for NWBT's ongoing brain cancer trial

Four medical centers enroll additional patients for NWBT's ongoing brain cancer trial

4 May 2011
WWP2 protein appears to play a key role in tumor survival

WWP2 protein appears to play a key role in tumor survival

4 May 2011
Ipsen first quarter sales increase 6.1% to €285.8 million

Ipsen first quarter sales increase 6.1% to €285.8 million

3 May 2011
FDA approves new targeted therapy to treat men with advanced prostate cancer

FDA approves new targeted therapy to treat men with advanced prostate cancer

3 May 2011
Statins can help reduce lung damage in severe abdominal sepsis

Statins can help reduce lung damage in severe abdominal sepsis

3 May 2011
USHIFU announces results from clinical investigation of Sonablate HIFU to treat prostate cancer

USHIFU announces results from clinical investigation of Sonablate HIFU to treat prostate cancer

30 Apr 2011
FDA approves Abbott's AndroGel for hypogonadism treatment in men

FDA approves Abbott's AndroGel for hypogonadism treatment in men

30 Apr 2011
Pelvic MRI scan identifies local recurrence of prostate cancer at low PSA levels

Pelvic MRI scan identifies local recurrence of prostate cancer at low PSA levels

29 Apr 2011
Injecting tissue spacers reduces risk of radiation burns to rectum in prostate cancer patients

Injecting tissue spacers reduces risk of radiation burns to rectum in prostate cancer patients

29 Apr 2011
MorphoSys reaches second clinical milestone with OncoMed Pharmaceuticals

MorphoSys reaches second clinical milestone with OncoMed Pharmaceuticals

29 Apr 2011
Centocor Ortho Biotech receives FDA approval for Zytiga to treat prostate cancer

Centocor Ortho Biotech receives FDA approval for Zytiga to treat prostate cancer

28 Apr 2011
FDA approves orphan drug designation for Cytrx’s INNO-206 to treat pancreatic cancer

FDA approves orphan drug designation for Cytrx’s INNO-206 to treat pancreatic cancer

28 Apr 2011
Celgene non-GAAP total revenue increases 40% to $1.11 billion

Celgene non-GAAP total revenue increases 40% to $1.11 billion

28 Apr 2011
Positive results from Sanofi-aventis and Regeneron ZALTRAP Phase III study in mCRC

Positive results from Sanofi-aventis and Regeneron ZALTRAP Phase III study in mCRC

27 Apr 2011

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback